Panagiotis Xaplanteris
Latest contributions
Intracoronary image interpretation: from operator to artificial intelligence
22 May 2025 – From EuroPCR 2025
Explore the evolving landscape of intracoronary image interpretation from operator-dependent assessments to artificial intelligence (AI) assistance. This session features variability analysis between novices and experts in OCT interpretation, AI-driven plaque segmentation and quantification, comparisons of stent expansion assessments by core labs and AI software, and insights...
Advanced tools for the diagnosis of coronary artery disease
22 May 2025 – From EuroPCR 2025
This session highlights advanced diagnostic tools for coronary artery disease, focusing on innovative pressure gradient assessments, computed tomography perfusion accuracy in stented patients, head-to-head comparisons of IQ-FFR with invasive FFR, and comprehensive evaluations of coronary physiology and plaque vulnerability derived from angiography.
Iatrogenic causes for shock treated with LV support
21 May 2025 – From EuroPCR 2025
Explore the management of iatrogenic causes of cardiogenic shock requiring left ventricular support. This session presents complex cases including shock following Bentall procedures, complications during anesthesia induction in bypass surgery, and strategic approaches to prevent and manage these critical scenarios using LV support devices.
Multimodality imaging and physiology for MINOCA diagnosis
20 May 2025 – From EuroPCR 2025
This session highlights the power of multimodality imaging and physiology in diagnosing MINOCA. Topics include detecting hidden plaque vulnerability, managing unexpected diagnoses beyond MINOCA, decision-making on stenting, AI's added value, and lessons from recurrent cases.
PCRonline @ ACC.25 Scientific Sessions
07 Feb 2025
Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2025 Scientific Sessions #ACC25
Artificial intelligence-based fully automated quantitative coronary angiography versus optical coherence tomography guidance for coronary stent implantation: a multicenter, randomised controlled non-inferiority trial (FLASH)
07 Nov 2024
Panos Xaplanteris provides his take on the FLASH trial presented by Jung-Min Ahn at TCT 2024 in Washington.
Author
PCR @ TCT 2024 - Get the international perspective!
11 Oct 2024
Thanks to the contribution of a team of interventional cardiologists from around the globe, get the international perspective on Late-breaking Clinical Trials and Science released at TCT 2024 - check out the list below.
RHEIA - Transcatheter versus surgical aortic valve replacement in women with severe aortic stenosis
01 Sep 2024
While Chiara De Biase interviews Helene Eltchaninoff about the RHEIA trial results, which she presented at the ESC Congress 2024 in London, Panos Xaplanteris shares his perspective on the trial, offering all the essential information and key takeaways you need for your practice!
Author
Author
Author
PCRonline @ ESC Congress 2024: the interventional cardiology perspective!
26 Jul 2024
What was new and hot in interventional cardiology at #ESCCongress 2024!
New frontiers in coronary physiology and imaging
15 May 2024 – From EuroPCR 2024
PCRonline @ ACC.24 Scientific Sessions
22 Mar 2024
Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2024 Scientific Sessions #ACC24
Protein and exercise to reverse frailty in older men and women undergoing transcatheter aortic valve replacement: The PERFORM-TAVR Trial
08 Apr 2024
Panos Xaplanteris provides his take on the results of PERFORM-TAVR presented by Jonathan Afilalo at ACC.24 in Atlanta.
Author
Pretreatment with P2Y12 inhibitors in ST-segment elevation myocardial infarction - insights from the Bern-PCI Registry
26 Jan 2024
This study sought to compare outcomes between patients presenting with STEMI before and after the recent ESC guidelines for the management of ACS recommend against pre-treatment with P2Y12 inhibitors in STEMI patients.
Reviewer
Reviewer
Concomitant left atrial appendage occlusion and transcatheter aortic valve replacement among patients with atrial fibrillation – The WATCH-TAVR Trial
26 Oct 2023
Panos Xaplanteris provides his take on WATCH-TAVR results which were presented by Samir R. Kapadia at TCT Congress 2023.
Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - The WATCH TAVR Trial
Author
PCRonline @ TCT 2023 - Get the international perspective!
17 Oct 2023
Thanks to the contribution of our team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science to be released at TCT 2023 - check out the list here!
PCRonline @ ESC Congress 2023: the interventional cardiology perspective!
07 Aug 2023
What was new and hot in interventional cardiology at #ESCCongress 2023!
ECLS-SHOCK: venoarterial membrane oxygenation in cardiogenic shock
27 Aug 2023
Panos Xaplanteris & Leonidas Koliastasis provide their take on the final results of the ECLS-SHOCK (Extracorporeal Life Support in Infarct-Related Cardiogenic Shock) which were presented by Holger Thiele during the ESC 2023 congress in Amsterdam.
Author
Author
PCI or CABG for left main coronary artery disease: the SWEDEHEART registry
28 Jun 2023
While the choice between PCI and CABG for LMCA disease continues to be one of the most controversial topics, patient characteristics & comorbidities must be taken into account, as must the external validity of the results of RCTs in the real world, as the SWEDEHEART registry does.
Reviewer
Reviewer
A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3G): one-year results of the BIOMAG-1 first-in-human study
25 May 2023
The 12-month outcomes of the BIOMAG-I first-in-human trial demonstrate a favorable safety profile for the third-generation magnesium scaffold and 38 % improved performance compared to its precursor.
Reviewer
Reviewer
The RADIANCE II study: two months outcomes of a randomized trial of renal denervation versus a sham procedure for uncontrolled moderate hypertension
19 Sep 2022
Panos Xaplanteris reports on the outcomes of the RADIANCE II study, presented by Dr Ajay Kirtane at TCT 2022, that evaluated the outcomes of ultrasound-based renal denervation for patients with uncontrolled moderate hypertension.
Author
PCRonline @ TCT 2022 - Get the international perspective!
12 Sep 2022
Thanks to the contribution of a team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science released at TCT 2022 - check out the list here!
ISCHEMIA-CKD EXTEND: revascularization does not improve outcomes at 5 years in patients with advanced chronic kidney disease
29 Aug 2022
Panagiotis Xaplanteris reports on the ISCHEMIA-CKD EXTEND trial results - clinical outcomes at 5 years of follow-up, which were presented during the ESC 2022 congress in Barcelona.
Author
PCRonline @ ESC Congress 2022: the interventional cardiology perspective!
18 Jul 2022
Stay up to date with what was new and hot in interventional cardiology at the #ESCCongress 2022!
Role of OCT in multivessel PCI
18 May 2022 – From EuroPCR 2022
How would you treat a 67-year-old male patient with dyslipidemia and family history of CAD, referred for coronary angiography because of severe, significant silent myocardial ischemia? Watch this LIVE case from Toulouse, France, to find out what your peers' choices are.
PCI for severe calcified lesions
18 May 2022 – From EuroPCR 2022
This session presents, LIVE from Toulouse, France, the management of a calcified LCx lesion in a 74-year-old patient with hypertension and NIDDM, scheduled for hip replacement surgery, and highlights the role of IVUS in optimising final angiographic results.
Angiography-derived physiological assessment of coronary artery stenosis severity and microvascular dysfunctions
18 May 2022 – From EuroPCR 2022
Follow the demonstrations of this EuroPCR 2022 session to understand the principles, clinical value, and applicability of coronary angiography-derived fractional flow reserve (caFFR), to discuss coronary angiography-derived index of microcirculatory resistance (caIMR) in the assessment of epicardial stenosis and coronary microcirculation, and to review data from available trials supporting these new...
EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary physiology: DECISION QFR, INOCA, and PROPHET-FFR
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in coronary physiology! Angiography-derived coronary microcirculatory assessment in INOCA patients, Heart Team decision-making based on angiography-derived FFR: DECISION QFR, and safety and efficacy of post-PCI physiological assessment: PROPHET-FFR.
New tools and techniques in coronary lesion assessment
17 May 2022 – From EuroPCR 2022
Consult this session to learn about new tools and techniques in coronary lesion assessment, such as: the ability of near infra-red spectroscopy to identify vulnerable patients and plaques, the iFR value impact on left internal mammary artery graft patency, the FFR-guided stent optimisation in focal and diffuse coronary...
Long LAD lesion treated by Robotic PCI - Session with LIVE case
17 May 2022 – From EuroPCR 2022
Learn more about this active 65-year-old patient with previous TIA, de novo angina, hypertension, normal cognitive functions, and physical examination who will be treated live from Toulouse, France in this session!
Transcatheter mitral edge intervention
17 May 2022 – From EuroPCR 2022
In this session, watch LIVE from Toulouse, France, an edge-to-edge transcatheter mitral valve repair on an 85-year-old male patient with severe primary mitral regurgitation and III NYHA shortness of breath, history of hypertension, NSTEMI in November 2019 resulting in PCI with DES on proximal and distal LADs,...
